(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]1COCC1)S(=O)(=O)C1=CC=C(N)C=C1](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10147_1621561404.gif?v=1742882114)
Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]1COCC1)S(=O)(=O)C1=CC=C(N)C=C1
RNA and protein synthesis inhibition
1-8H3/b13-12-
decrease the phosphorylation of mitogen-activated protein kinases (MAPKs)
InChiKey: OONFNUWBHFSNBT-HXUWFJFHSA-N
BMN-673 - CAS# 1207456-01-6 Catalog No.:M10147-2 CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]1COCC1)S(=O)(=O)C1=CC=C(N)C=C1BMN 673, also known as Talazoparib and MDV 3800, is an orally bioavailable inhibitor of the nuclear enzyme poly(ADP ribose) polymerase (PARP) with potential antineoplastic activity (PARP1 IC50 = 0. 57 nmol L). Product information CAS Number: 1207456 01 6 Molecular Weight: 380. 35 Formula: C19H14F2N6O Synonym: Talazoparib BMN673 BMN 673 Chemical Name: (11S,12R) 7 fluoro 11 (4 fluorophenyl) 12 (1 methyl 1H 1,2,4 triazol 5 yl) 2,3,10 triazatricyclo[7. 3.